YM-274, PG-490-88
4-[(3bS,4aS,5aR,6R,6aS,7aS,7bS,8aS,8bS)-6a-异丙基-8b-甲基-1-氧代-1,3,3b,4,4a,6,6a,7a,7b,8b,9,10-十二氢三氧基酸盐[6,7:8a,9:4b,5]phenanthro[1,2-c]呋喃-6-酰氧基]-4-氧丁酸钠盐 昂曲托来 Chemical Name: 4-[(3bS,4aS,5aR,6R,6aS,7aS,7bS,8aS,8bS)-6a-Isopropyl-8b-methyl-1-oxo-1,3,3b,4,4a,6,6a,7a,7b,8b,9,10-dodecahydrotrisoxireno[6,7:8a,9:4b,5]phenanthro[1,2-c]furan-6-yloxy]-4-oxobutyric acid sodium salt
CAS No. 195883-09-1, 195883-06-8 (free acid), 195883-07-9 (tromethamine salt)
项目整合开发状态: Phase I
项目研究机构: Duke University (Originator), Pharmagenesis (Originator), Stanford University (Originator), Pierre Fabre (Licensee)
合成路线:The title compound is a semisynthetic derivative of triptolide (I),a substance isolated from the root xylem of the Chinese medicinal plant Tripterygium wilfordii.Condensation of (I) with succinic anhydride (II) in hot pyridine furnished the corresponding hemisuccinate ester.This was converted to the corresponding sodium salt by treatment with aqueous NaHCO3 and then isolated by lyophilization of the filtered solution.
📌 参考资料/链接:
参考文献标题:Immunosuppressive cpds.and methods
文献作者:Qi,Y.M.; Musser,J.H.; Fidler,J.M.(Pharmagenesis,Inc.)
参考来源:EP 0907652; JP 2001504437; US 5663335; US 5962516; WO 9731920; WO 9731921